Provided by Tiger Trade Technology Pte. Ltd.

ASTRAZENECA PLC ADRhedged

53.28
0.0000
Volume:- -
Turnover:- -
Market Cap:1.60M
PE:- -
High:53.28
Open:53.28
Low:53.28
Close:53.28
52wk High:56.90
52wk Low:44.36
Shares:30.00K
Float Shares:10.00K
Volume Ratio:2.68
T/O Rate:- -
Dividend:0.58
Dividend Rate:1.08%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Vertex Pharmaceuticals Inc Stock (VRTX) Opened Up by 9.76% on Aug 10: What Investors Need To Know

TradingKey
·
Aug 10

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

AstraZeneca May Abandon Decade-Long M&A Strategy, Pursuing Mega Deal to Secure US Market Scale

Deep News
·
Aug 06

Deal or no Deal, AstraZeneca Stock is a Bargain

Dow Jones
·
Aug 06

AstraZeneca, Jaguar Land Rover Gain Access to UK's Fast-Track Visa

MT Newswires Live
·
Aug 06

Wall Street Warms to Healthcare Stocks as Tech Trade Faces Turbulence

Reuters
·
Aug 05

Unusually active option classes on open August 5th

TIPRANKS
·
Aug 05

Bristol Myers, AstraZeneca not engaged in merger talks, Reuters reports

TIPRANKS
·
Aug 05

AstraZeneca PLC Stock (AZN) Moved Up by 4.30% on Aug 5: A Full Analysis

TradingKey
·
Aug 05

Market Chatter: AstraZeneca, Bristol Myers Not Pursuing Merger Talks

MT Newswires Live
·
Aug 05

AstraZeneca deal talks with Bristol Myers remain active, Semafor says

TIPRANKS
·
Aug 05

AstraZeneca Advances Tuesday, Outperforms Market

Dow Jones
·
Aug 05

Bristol Myers Squibb Potential Deal With AstraZeneca Seen Unlikely as Shareholder Views Diverge, RBC Says

MT Newswires Live
·
Aug 04

AstraZeneca (AZN) Gets a Sell from Deutsche Bank

TIPRANKS
·
Aug 04

AstraZeneca (AZN) Receives a Buy from UBS

TIPRANKS
·
Aug 04

More Biotech M&A is Coming, Whether an AstraZeneca-Bristol Myers Deal Happens or Not

Dow Jones
·
Aug 04

An AstraZeneca, Bristol Myers Squibb Merger Could Create a Cancer-Drug Giant, but Analysts Call it 'odd'

Dow Jones
·
Aug 04

TD Cowen sees no strategic logic in an AstraZeneca-Bristol Myers merger

TIPRANKS
·
Aug 04

AstraZeneca’s Elecoglipron Trial: Early Signals for a Future Oral Metabolic Franchise

TIPRANKS
·
Aug 04

AstraZeneca Slides Monday, Underperforms Market

Dow Jones
·
Aug 04